Readdi Inc.
Fiscal year ending 2024. Filed on February 6, 2025.
PO Box 110087
Durham, North Carolina 27709
Readdi Inc. (EIN: 88-3812342) has filed an IRS Form 990 since fiscal year 2023. In its fiscal year 2024 IRS Form 990 filing, Readdi Inc., a 501(c)(3) charitable organization, reported compensation for 7 employees. Among the employees shown here, the average compensation is $403,406. The highest compensated employee at Readdi Inc. is J Christopher Clemens with fiscal year 2024 compensation of $560,018.
Revenue, expenses, and employee compensation
Revenue
Expenses
Employee compensation
Reported Compensated Employees
Mission Statement
THE RAPIDLY EMERGING ANTIVIRAL DRUG DEVELOPMENT INITIATIVE (READDI) IS A NONPROFIT BIOTECHNOLOGY ORGANIZATION DEDICATED TO PREVENTING GLOBAL CATASTROPHES CAUSED BY VIRUSES. IT PLAYS A CLEAR, SPECIFIC AND CENTRAL ROLE IN THE WIDELY ACCEPTED THREE-PRONGED PANDEMIC PREPAREDNESS APPROACH INVOLVING DIAGNOSTICS, THERAPEUTICS AND VACCINES. READDI DEVELOPS THERAPEUTICS.
Revisions to this organization profile
Get an email when new compensation information is released for Readdi Inc.
Be the first to know when new IRS Form 990 data is published for this organization.